Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystrophy. Nature Communications. 2022; 13.
.Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nature Communications. 2021; 12.
.Cardiac Cell Therapy Fails to Rejuvenate the Chronically Scarred Rodent Heart. Circulation. 2021; 144:328-331.
.Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020. PLoS ONE. 2021; 16.
.MCUb Induction Protects the Heart From Postischemic Remodeling. Circulation Research. 2020; 127:379-390.
.Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection but Not by Vascular Infusion. Circulation. 2020; 141:1037-1039.
.An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2020; 577:405-409.
.Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability. Nature Communications. 2019; 10.
.Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Science advances. 2019; 5.
.Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart. JCI insight. 2019; 4.
.Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. Journal of Clinical Investigation. 2018; 128:2127-2143.
.BEX1 is an RNA-dependent mediator of cardiomyopathy. Nature Communications. 2017; 8.
.Caveolae-localized L-type Ca2+ channels do not contribute to function or hypertrophic signalling in the mouse heart. Cardiovascular Research. 2017; 113:749-759.
.A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy. Cell. 2016; 165:1147-1159.
.Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice. Journal of Biological Chemistry. 2016; 291:9920-9928.
.c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014; 509:337-341.
.Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystrophy. Nature Communications. 2022; 13.
.Remembering Jeff Robbins: The Father of Cardiac Transgenesis. JACC: Basic to Translational Science. 2022; 7:1063-1065.
.Loss of Acta2 in cardiac fibroblasts does not prevent the myofibroblast differentiation or affect the cardiac repair after myocardial infarction. Journal of Molecular and Cellular Cardiology. 2022; 171:117-132.
.Ca2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons. Science advances. 2022; 8.
.At the Brink of Human Therapy to Generate New Myocytes in the Adult Injured Heart. Circulation. 2022; 145:1356-1358.
.2022; 1:312-321.
. Fibroblasts orchestrate cellular crosstalk in the heart through the ECM.Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nature Communications. 2021; 12.
.Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia. Circulation. 2021; 144:539-555.
.Cardiac Cell Therapy Fails to Rejuvenate the Chronically Scarred Rodent Heart. Circulation. 2021; 144:328-331.
.Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020. PLoS ONE. 2021; 16.
.Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts. Journal of Visualized Experiments. 2021.
.Resident macrophages keep mitochondria running in the heart. Cell Research. 2020; 30:1057-1058.
.MCUb Induction Protects the Heart From Postischemic Remodeling. Circulation Research. 2020; 127:379-390.
.A 20/20 view of ANT function in mitochondrial biology and necrotic cell death. Journal of Molecular and Cellular Cardiology. 2020; 144:A3-A13.
.Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection but Not by Vascular Infusion. Circulation. 2020; 141:1037-1039.
.An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2020; 577:405-409.
.Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability. Nature Communications. 2019; 10.
.Overlapping and differential functions of ATF6α versus ATF6β in the mouse heart. Scientific Reports. 2019; 9.
.CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart. Molecular Therapy. 2019; 27:1869-1871.
.Hippo signaling does it again: arbitrating cardiac fibroblast identity and activation. Genes and Development. 2019; 33:1457-1459.
.Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Science advances. 2019; 5.
.Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart. JCI insight. 2019; 4.
.Disruption of valosin-containing protein activity causes cardiomyopathy and reveals pleiotropic functions in cardiac homeostasis. Journal of Biological Chemistry. 2019; 294:8918-8929.
.ERK1/2 signaling induces skeletal muscle slow fiber-type switching and reduces muscular dystrophy disease severity. JCI insight. 2019; 5.
.Genetic Lineage Tracing of Sca-1+ Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart. Circulation. 2018; 138:2931-2939.
.The mitochondrial calcium uniporter underlies metabolic fuel preference in skeletal muscle. JCI insight. 2018; 3.
.Gata4-Dependent Differentiation of c-Kit+-Derived Endothelial Cells Underlies Artefactual Cardiomyocyte Regeneration in the Heart. Circulation. 2018; 138:1012-1024.
.Undeniable Evidence That the Adult Mammalian Heart Lacks an Endogenous Regenerative Stem Cell. Circulation. 2018; 138:806-808.
.Defective Flux of Thrombospondin-4 through the Secretory Pathway Impairs Cardiomyocyte Membrane Stability and Causes Cardiomyopathy. Molecular and Cellular Biology. 2018; 38.
.New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications. Circulation Research. 2018; 123:159-176.
.2018; 3:57-62.
. Identity of the elusive mitochondrial permeability transition pore: what it might be, what it was, and what it still could be.Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. Journal of Clinical Investigation. 2018; 128:2127-2143.
.van Berlo et al. reply. Nature. 2018; 555.
.
Jeffery D. Molkentin, PhD
Professor, Howard Hughes Medical Institute
Molecular Cardiovascular Biology
240 Albert Sabin Way
MLC 7020
Cincinnati, OH 45229-3039
Phone: 513-636-3557
Email: jeff.molkentin@cchmc.org